Aspect Partners
RMD icon

Aspect Partners’s ResMed RMD Stock Holding History

Aspect Partners’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$884 Hold
4
– – ﹤0.01% 594
2026
Q2 		$780 Buy
4
+1
+33% +$207 ﹤0.01% 604
2026
Q1 		$673 Hold
3
– – ﹤0.01% 637
2025
Q4 		$723 Buy
+3
New +$767 ﹤0.01% 655

Other funds holding RMD

Vest Financial
Vest Financial Mclean, Virginia $9.5B AUM 22.78% 1-Year Est. Return
Washington Trust Advisors
Washington Trust Advisors Wellesley, Massachusetts $1.4B AUM 26.88% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Confluence Investment Management
Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return
MassMutual Private Wealth & Trust
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
Fideuram - Intesa Sanpaolo Private Banking
Fideuram - Intesa Sanpaolo Private Banking Turin $3.5B AUM 45.13% 1-Year Est. Return
NorthCrest Asset Manangement
NorthCrest Asset Manangement Plymouth, Minnesota $4.24B AUM 32.82% 1-Year Est. Return
Addenda Capital
Addenda Capital Montreal, Quebec, Canada $3.78B AUM 23.53% 1-Year Est. Return

Aspect Partners's RMD Position: Q3 2026 in Review

Aspect Partners held its ResMed (RMD) position steady in Q3 2026 at 4 shares worth $884. The position accounts for ﹤0.01% of the portfolio, ranked #594.

Aspect Partners first reported a position in RMD in Q4 2025 and has held it in 4 quarters since. 186 funds tracked by Wall St. Rank hold RMD as of Q3 2026.

  • Aspect Partners held 4 shares of ResMed worth $884 as of Q3 2026.
  • Aspect Partners left its ResMed share count unchanged in Q3 2026.
  • ResMed made up ﹤0.01% of Aspect Partners's portfolio in Q3 2026, its #594 holding.
  • Aspect Partners first reported a position in ResMed in Q4 2025 and has held it in 4 quarters since.
  • 186 funds tracked by Wall St. Rank held ResMed as of Q3 2026.

Based on Aspect Partners's 13F filing for Q3 2026, filed 20 Oct 2026.